Temasek Trims Positions in Celltrion and Celltrion Healthcare
Posted on 04/02/2020
Singapore’s Temasek Holdings, through its unit Ion Investments B.V., sold 2.57 million shares (1.97% ownership) of South Korea-based Celltrion Inc., and sold 2.21 million shares (1.5% ownership) of Celltrion Healthcare Co. Ion Investments retrieved some 619 billion KRW. Celltrion stock sold at 178,695 KRW, 9.8% off the closing price on April 1, 2020. A share […]
